Pan-cancer studies have also shown that the ability of GPNMB to activate the PI3K-AKT pathway is positively correlated with the metastatic potential of tumors, and inhibition of its expression significantly reduces the invasiveness of DLBCL cells (36, 37). The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.